Director, Department of Molecular Imaging and Therapy, Austin Health; Tumour Targeting Program Lead, Olivia Newton-John Cancer Research Institute; Research and Commercialisation Lead, VCCC Alliance; Professor, the University of Melbourne and La Trobe Univ
Prof Andrew Scott's clinical and research interests are in molecular imaging of cancer, target discovery and therapeutics development, and conduct of first-in-human and multi-centre clinical trials. He is a Fellow of the Royal Australasian College of Physicians, Fellow of the Australian Academy of Health and Medical Sciences, Fellow of the Australian Institute of Company Directors, and in 2017 was awarded Member (AM) in the General Division of the Order of Australia. Prof Andrew Scott has published 453 peer reviewed papers and 28 book chapters, is an inventor on 27 patents, and has received over $40 million in peer reviewed grant funding in the last 5 years.